https://www.selleckchem.com/products/abt-199.html
These findings would help in the future development of preventive and therapeutic interventions targeting FcµR. To systematically appraise the implementation of cochlear implantation (CI) in Usher Syndrome (USH) Types 1, 2, and 3 patients, and analyze who would benefit from CI. A comprehensive search of PubMed, Embase, CINAHL, and Cochrane Library electronic databases from inception through June 2020 was performed. There were no language restrictions. The PRISMA strategy was followed. Included studies discuss USH patients who underwent
Like
Comment
Share
